Cargando…
Effect of anti-vascular endothelial growth factor on the surgical outcome of neovascular glaucoma: An overview and meta-analysis
BACKGROUND: Bevacizumab is known to be very effective in inhibiting ocular neovascularization in neovascular glaucoma (NVG). The purpose of this study is to evaluate the effect of anti-vascular endothelial growth factor on the surgical outcome of Ahmed glaucoma valve implantation (AGVI) in NVG. METH...
Autores principales: | Hwang, Hyung Bin, Lee, Na Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483822/ https://www.ncbi.nlm.nih.gov/pubmed/34596134 http://dx.doi.org/10.1097/MD.0000000000027326 |
Ejemplares similares
-
Surgical treatment of neovascular glaucoma with Ex-PRESS glaucoma shunt: Case report
por: Yu, Teng-Chieh, et al.
Publicado: (2017) -
Influence of vitreomacular interface on anti-vascular endothelial growth factor treatment outcomes in neovascular age-related macular degeneration: A MOOSE-compliant meta-analysis
por: Gao, Meng, et al.
Publicado: (2017) -
Intracameral air injection during Ahmed glaucoma valve implantation in neovascular glaucoma for the prevention of tube obstruction with blood clot: Case Report
por: Hwang, Sung Ha, et al.
Publicado: (2017) -
Changes in inner retinal layer thickness in patients with exudative age-related macular degeneration during treatment with anti-vascular endothelial growth factor
por: Lee, Seong Woo, et al.
Publicado: (2020) -
Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy
por: Kwon, Jin-woo, et al.
Publicado: (2017)